Calvert, Peter http://orcid.org/0000-0002-8401-4033
Ding, Wern Yew
Das, Moloy
Tovmassian, Lilith
Tayebjee, Muzahir H.
Haywood, Guy
Martin, Claire A.
Rajappan, Kim
Bates, Matthew G. D.
Temple, Ian Peter
Reichlin, Tobias
Chen, Zhong
Balasubramaniam, Richard N.
Sticherling, Christian
Ronayne, Christina
Clarkson, Nichola
Morgan, Maureen
Barton, Janet
Kemp, Ian
Mahida, Saagar
Gupta, Dhiraj
Funding for this research was provided by:
Medtronic Europe (AF-3908)
Article History
Received: 15 January 2024
Accepted: 4 March 2024
First Online: 13 March 2024
Declarations
:
: DG was a speaker for Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Medtronic, Biosense Webster and Boston Scientific and a proctor for Abbott and received research grants from Medtronic, Biosense Webster and Boston Scientific. MD received fellowship funding from Biosense Webster and Boston Scientific, research funding from Boston Scientific and speaker fees from Boston Scientific and BMS/Pfizer. CAM received speaker fees and research grants from BSCI and Medtronic and speaker fees from Biosense Webster for work outside the submitted study. TR received research grants from the Goldschmidt–Jacobson Foundation, the Swiss National Science Foundation, the Swiss Heart Foundation, the European Union (Eurostars 9799–ALVALE), the Professor Max Cloëtta Foundation, the Cardiovascular Research Foundation Basel, the University of Basel and the University Hospital Basel; speaker/consulting honoraria or travel support from Abbott/SJM, Astra Zeneca, Brahms, Bayer, Biosense-Webster, Biotronik, Boston-Scientific, Daiichi Sankyo, Medtronic, Pfizer-BMS and Roche; and support for his institution’s fellowship programme from Abbott/SJM, Biosense-Webster, Biotronik, Boston-Scientific and Medtronic. CS reported grants and lecture fees from Biosense Webster and Medtronic and served as a proctor for Biosense Webster and Medtronic. Other authors have no relevant disclosures to declare.